DEA Schedule CV
Strength
225 mg/1
Manufacturer
Cipla USA Inc.NDC
69097068405
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA212280On Market Since
1/10/2020
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
No related drugs found.